Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pivotal Study of Bexxar in Refractory Low-Grade or Transformed NHL
NCT00989664Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 1996
- Primary completion
- Jan 2004
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of tositumomab in Non-Hodgkin lymphoma (NHL), sponsored by GSK. Started Nov 1996; status: completed.
02
Drugs
tositumomab
03
Conditions
Non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00989664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00989664.